Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- Pakistan
- Region
- Asia
Regulatory licences
- DMLName on licence: Cell Health Sciences,
Registered products
33 products
Sixime 400 mg capsCefixime as Trihydrate 400mg(JP Specifications)400mgSixone 1 gm Inj (IV)Each vial of dry substance contains:-Sterile Ceftrioxone (as Sodium) 1gm(USP Specifications)1gmSixone 250 mg Inj (IM)Each vial of dry substance contains:-Sterile Ceftrioxone (as Sodium) 250mg(USP Specifications)250mgSixone 250 mg Inj (IV)Each vial of dry substance contains:-Sterile Ceftrioxone (as Sodium) 250mg(USP Specifications)250mgSixone 500 mg Inj (IM)Each vial of dry substance contains:-Sterile Ceftrioxone (as Sodium) 500mg(USP Specifications)500mgSixone 500 mg Inj (IV)Each vial of dry substance contains:-Sterile Ceftrioxone (as Sodium) 500mg(USP Specifications)500mgStrem 8 mg tabsOndansetron (as Hydrochloride) 8mg(USP Specifications )8mgZesin 250 mg capsAzithromycin (as Dihydrate) USP 250mg(USP Specs.)250mgZesin 500 mg capsAzithromycin (as Dihydrate) USP 500mg(USP Specs.)500mg
